Get the Stockscreener App
2.75
1.08%
-0.03
Puma Biotechnology Inc Stock (PBYI) Forecast
The Puma Biotechnology Inc (PBYI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.8448, representing a +39.81% increase from the current price of $2.75. The highest analyst price target is $3.555, and the lowest is $4.1345.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PBYI Price Target
Average 1.8639
(-32.22% Downside)
Is Puma Biotechnology Inc (PBYI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 42.03 | Neutral |
| STOCH(9,6) | 17.42 | Buy |
| STOCHRSI(14) | 2.5547 | Buy |
| MACD(12,26) | -0.0402 | Sell |
| ADX(14) | 15.06 | Neutral |
| William %R | -95.45 | Buy |
| CCI(14) | -83.02 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.89
Sell
|
2.8855
Sell
|
| MA20 |
3.025
Sell
|
2.9379
Sell
|
| MA50 |
2.942
Sell
|
2.9323
Sell
|
| MA100 |
2.8487
Sell
|
3.034
Sell
|
| MA200 |
3.582
Sell
|
3.2719
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, PBYI could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on PBYI, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 42.03 indicates that PBYI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 17.42 indicates that PBYI is oversold. This indicates that PBYI price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.5547 indicates that PBYI is oversold. This suggests that PBYI price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 15.06 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -83.02 indicates that PBYI is still oversold but not to an extreme extent.
Long-term PBYI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Puma Biotechnology Inc financial reports and earnings history, Puma Biotechnology Inc (PBYI) stock could reach $12.67 by 2030, $14.41 by 2040 and $38.10 by 2050. See the projected annual prices until 2050 of the Puma Biotechnology Inc stock below:
- Puma Biotechnology Inc (PBYI) is expected to reach an average price of $4.8302 in 2035, with a high prediction of $6.8225 and a low estimate of $5.4602. This indicates an $75.64% rise from the last recorded price of $2.75.
- Puma Biotechnology Inc (PBYI) stock is projected to chart a bullish course in 2040, with an average price target of $14.55, representing an $429.00% surge from its current level. The forecast ranges from a conservative $14.57 to a sky-high $14.41.
- Our analysts predict Puma Biotechnology Inc (PBYI) to jump 812.49% by 2045, soaring from $25.15 to an average price of $25.09, potentially reaching $25.15. While $25.15 is the low estimate, the potential upside is significant.
- Puma Biotechnology Inc (PBYI) stock is expected to climb by 2050, reaching an average of $36.71, a $1,235% jump from its current level. However, a wide range of estimates exists, with high and low targets of $38.10 and $37.58, respectively, highlighting the market's uncertainty.
Puma Biotechnology Inc Stock (PBYI) Year by Year Forecast
Puma Biotechnology Inc Stock (PBYI) Price Forecast for 2025
Puma Biotechnology Inc Stock (PBYI) is expected to reach an average price of $1.8639 in 2025, with a high prediction of $3.6003 and a low estimate of $0.1275. This indicates an -32.22% fall from the last recorded price of $2.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.9514 | $4.1345 | $3.555 | +43.69% |
| February, 2025 | $4.3553 | $4.2074 | $3.6003 | +58.37% |
| March, 2025 | $1.7741 | $0.1482 | $2.8418 | -35.49% |
| April, 2025 | $3.4939 | $2.0801 | $3.1139 | +27.05% |
| May, 2025 | $0.6677 | $2.4476 | $3.5758 | -75.72% |
| June, 2025 | $1.0084 | $0.4316 | $2.1483 | -63.33% |
| July, 2025 | $0.2714 | $0.1275 | $1.8025 | -90.13% |
| August, 2025 | $0.9252 | $1.1393 | $0.8627 | -66.36% |
| September, 2025 | $0.919 | $1.5231 | $1.711 | -66.58% |
| October, 2025 | $1.3888 | $1.2429 | $0.5879 | -49.50% |
| November, 2025 | $0.7927 | $1.1377 | $0.8648 | -71.18% |
| December, 2025 | $2.3425 | $0.9146 | $1.0005 | -14.82% |
Puma Biotechnology Inc Stock (PBYI) Price Forecast for 2026
The predicted value for Puma Biotechnology Inc (PBYI) in 2026 is set at an average of $2.0026. Estimates vary from a peak of $3.9722 to a trough of $0.033, indicating an -27.18% surge from the present price of $2.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.1537 | $0.2437 | $1.7484 | -58.05% |
| February, 2026 | $0.6599 | $0.2001 | $2.6518 | -76.01% |
| March, 2026 | $0.476 | $0.178 | $1.8139 | -82.69% |
| April, 2026 | $1.5962 | $0.0901 | $3.9722 | -41.96% |
| May, 2026 | $0.9424 | $0.1457 | $1.9703 | -65.73% |
| June, 2026 | $0.5315 | $0.1855 | $1.2164 | -80.67% |
| July, 2026 | $0.5588 | $0.0507 | $0.8607 | -79.68% |
| August, 2026 | $1.7949 | $0.2468 | $2.3949 | -34.73% |
| September, 2026 | $1.1049 | $0.033 | $1.979 | -59.82% |
| October, 2026 | $2.1587 | $1.3608 | $1.4987 | -21.50% |
| November, 2026 | $1.5426 | $1.7126 | $1.8206 | -43.91% |
| December, 2026 | $1.9373 | $1.7785 | $2.0364 | -29.55% |
Puma Biotechnology Inc Stock (PBYI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Puma Biotechnology Inc (PBYI) is $4.1518, with a high forecast of $5.8454 and a low forecast of $2.4583. This indicates an +50.98% increase from the last price of $2.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.1362 | $2.4583 | $2.7162 | +14.04% |
| February, 2027 | $5.25 | $3.8521 | $4.85 | +90.91% |
| March, 2027 | $4.9198 | $5.536 | $5.3419 | +78.90% |
| April, 2027 | $5.5836 | $5.2158 | $5.5136 | +103.04% |
| May, 2027 | $5.8075 | $5.8975 | $5.8015 | +111.18% |
| June, 2027 | $5.5373 | $5.8413 | $5.8454 | +101.36% |
| July, 2027 | $5.0411 | $5.2052 | $4.9532 | +83.31% |
| August, 2027 | $5.065 | $4.853 | $4.87 | +84.18% |
| September, 2027 | $5.5447 | $5.4259 | $5.7316 | +101.63% |
| October, 2027 | $4.8086 | $5.0226 | $5.4407 | +74.86% |
| November, 2027 | $4.4124 | $4.6765 | $4.486 | +60.45% |
| December, 2027 | $3.6622 | $3.7522 | $4.0384 | +33.17% |
Puma Biotechnology Inc Stock (PBYI) Price Forecast for 2028
In 2028, Puma Biotechnology Inc (PBYI) is projected to reach an average price of $3.1494, with a high projection of $4.4578 and a low estimate of $1.841. This indicates an +14.52% rise from the last price of $2.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.4561 | $4.0882 | $4.3461 | +62.04% |
| February, 2028 | $4.5299 | $4.573 | $4.4549 | +64.72% |
| March, 2028 | $4.5497 | $4.5497 | $4.4578 | +65.44% |
| April, 2028 | $2.3335 | $2.8556 | $3.9556 | -15.14% |
| May, 2028 | $2.3033 | $2.1374 | $1.9545 | -16.24% |
| June, 2028 | $1.9071 | $1.9162 | $2.0643 | -30.65% |
| July, 2028 | $1.761 | $1.841 | $1.7691 | -35.96% |
| August, 2028 | $3.3908 | $2.0269 | $2.7808 | +23.30% |
| September, 2028 | $2.8346 | $3.0946 | $3.3677 | +3.08% |
| October, 2028 | $2.5585 | $2.9506 | $2.9275 | -6.97% |
| November, 2028 | $1.9882 | $2.3082 | $2.6804 | -27.70% |
| December, 2028 | $1.8721 | $2.0411 | $1.8902 | -31.92% |
Puma Biotechnology Inc Stock (PBYI) Price Forecast for 2029
The 2029 price forecast for Puma Biotechnology Inc Stock (PBYI) is $2.9261 on average, with a high prediction of $5.655 and a low estimate of $0.1972. This represents an +6.40% increase from the previous price of $2.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.6119 | $1.6319 | $1.844 | -41.39% |
| February, 2029 | $1.3857 | $1.4538 | $1.2457 | -49.61% |
| March, 2029 | $1.8996 | $1.3776 | $1.4996 | -30.93% |
| April, 2029 | $2.4634 | $2.1155 | $2.2834 | -10.42% |
| May, 2029 | $1.1532 | $1.9332 | $2.3253 | -58.07% |
| June, 2029 | $0.767 | $0.7511 | $0.567 | -72.11% |
| July, 2029 | $0.0509 | $0.2229 | $0.2649 | -98.15% |
| August, 2029 | $0.4894 | $0.1972 | $1.3913 | -82.21% |
| September, 2029 | $2.4755 | $0.3874 | $3.6215 | -9.98% |
| October, 2029 | $1.4257 | $0.2357 | $3.1096 | -48.16% |
| November, 2029 | $1.2419 | $1.1319 | $2.2528 | -54.84% |
| December, 2029 | $8.69 | $0.9859 | $5.655 | +216.00% |
Puma Biotechnology Inc Stock (PBYI) Price Forecast for 2030
Puma Biotechnology Inc Stock (PBYI) is expected to reach an average price of $14.75 in 2030, with a high forecast of $18.39 and a low forecast of $11.11. This signifies an +436.45% surge from the last price of $2.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $14.05 | $11.11 | $12.67 | +411.08% |
| February, 2030 | $14.94 | $14.06 | $14.07 | +443.17% |
| March, 2030 | $17.32 | $16.45 | $16.66 | +530.00% |
| April, 2030 | $15.42 | $15.62 | $14.86 | +460.82% |
| May, 2030 | $15.01 | $15.22 | $14.76 | +445.90% |
| June, 2030 | $18.23 | $16.00 | $18.39 | +563.09% |
| July, 2030 | $16.06 | $17.36 | $18.13 | +483.98% |
| August, 2030 | $16.65 | $15.99 | $15.32 | +505.35% |
| September, 2030 | $16.14 | $16.53 | $15.94 | +487.08% |
| October, 2030 | $12.18 | $12.57 | $15.81 | +343.07% |
| November, 2030 | $16.90 | $12.26 | $13.29 | +514.62% |
| December, 2030 | $16.76 | $15.74 | $15.40 | +509.45% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):